Healthcare - Drug Manufacturers - General - NYSE - US
$ 164.99
-2.74 %
$ 292 B
Market Cap
57.69
P/E
Price Target
Average
21.54%
Revenue Forecast
Estimate
7.07%
EBIT
Estimate
19.48%
Net Income
Estimate
56.50%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
AbbVie Inc.
Wall Street analysts predict an average 1-year price target for ABBV of $201 , with forecasts ranging from a low of $175 to a high of $228 .
ABBV Lowest Price Target
Wall Street Target
175 USD
6.07%
ABBV Average Price Target
Wall Street Target
201 USD
21.54%
ABBV Highest Price Target
Wall Street Target
228 USD
38.19%
REVENUE FORECAST
Revenue Forecast Chart ABBV
EBIT FORECAST
EBIT Forecast Chart ABBV
NET INCOME FORECAST
Net Income Chart ABBV